Back to search
Non-Small Cell Lung Cancer Stage IIIB
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Lung Cancer Stage IIIB trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Lung Cancer Stage IIIB trials you may qualify forThis phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating pat…
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small c…
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving patholog…
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metastatic Non-Small Cell Lung Cancer (NSCLC)…
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that h…
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell…
This study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small…
This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab…